Zogenix MDS, Inc. clinical trials
Acquired by UCB S.A., Mar 7, 2022 · source ↗
The registry lists 3 studies whose lead sponsor is Zogenix MDS, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 1, 2023.
Before and after it joined UCB S.A.
- First submitted before Zogenix MDS, Inc. became part of UCB S.A.
- 3
- First submitted after Zogenix MDS, Inc. became part of UCB S.A.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Zogenix MDS, Inc.3 studies
Something wrong with this grouping? Tell us on the UCB S.A. page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All UCB S.A. studies →
- A RETROspective Study of Patients With TK2dCompletedNCT03701568
Sponsor listed in the registry: Zogenix MDS, Inc. · First submitted before Zogenix MDS, Inc. became part of UCB S.A.
- A Retrospective Study of Subjects With Thymidine Kinase 2 DeficiencyCompletedNCT05017818
Sponsor listed in the registry: Zogenix MDS, Inc. · First submitted before Zogenix MDS, Inc. became part of UCB S.A.
- A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve)WithdrawnNCT04581733Phase 3
Sponsor listed in the registry: Zogenix MDS, Inc. · First submitted before Zogenix MDS, Inc. became part of UCB S.A.